Related by context. All words. (Click for frequent words.) 59 mechanically ventilated patients 59 recurrent venous thromboembolism 58 FDA defined valvulopathy 58 postoperative infection 58 periprocedural 57 platelet reactivity 57 reintervention 57 inhospital mortality 57 thromboembolism 57 intima media thickness 57 % CI #.#-#.# [008] 56 postoperative AF 56 glomerular filtration 56 p ≤ 56 preintervention 56 % CI #.#-#.# [007] 56 HbA 1c levels 56 segment binary restenosis 56 perioperative complications 56 inhospital 56 coronary stenosis 56 nondiabetic patients 55 annualized relapse 55 P = .# 55 thromboembolic 55 reinfarction 55 perioperative mortality 55 leukocyte count 55 infarct size 55 angiographic restenosis 55 recurrent VTE 55 binary restenosis 55 p = NS 54 acute cholecystitis 54 Stent thrombosis 54 Operative mortality 54 lymphocytosis 54 % CI #.#-#.# [003] 54 arterial thromboembolic events 54 variceal 54 SGRQ 54 MACCE 54 venous thromboembolic disease 54 morphometric vertebral fractures 54 pulmonary capillary wedge 54 tirofiban 54 postoperative infections 54 symptomatic intracranial 54 nonvertebral fracture 54 #.#/#.# mmHg [001] 54 locoregional disease 54 postintervention 54 glycated hemoglobin levels 54 CR nPR 54 recurrent atrial fibrillation 54 polyp recurrence 53 confidence interval CI 53 postoperative atrial fibrillation 53 clinically evaluable patients 53 deep venous thromboses 53 rebleeding 53 normothermia 53 related bloodstream infections 53 complete cytogenetic response 53 OPCAB 53 carotid artery stenting CAS 53 locoregional recurrence 53 % CI #.#-#.# [001] 53 recurrent myocardial infarction 53 carotid artery thickness 53 definite stent thrombosis 53 hemorrhagic complications 53 imipenem 53 graft patency 53 Secondary endpoints include 53 HBeAg seroconversion 53 confirmed CCyR 53 postoperative mortality 53 tumor recurrence 53 acute GVHD 53 pancreatic fistula 53 p = ns 53 recurrent DVT 53 mcg QD 53 pT3 53 LV dysfunction 53 CIMZIA TM certolizumab pegol 53 NYHA functional class 53 drotrecogin alfa activated 53 invasive aspergillosis 53 antithrombotic therapy 53 p = #.# [003] 53 retransplantation 53 postoperative pulmonary 53 variceal bleeding 53 symptomatic intracranial hemorrhage 53 sustained virological response 53 arterial thrombotic 53 mmHg diastolic 52 IOP lowering 52 fibrinolysis 52 DES implantation 52 thromboembolic events 52 DAS# CRP 52 hemoglobin A1c levels 52 left ventricular systolic 52 Kaplan Meier estimates 52 postprocedure 52 clodronate 52 refractory ischemia 52 ximelagatran 52 VAD implantation 52 -#.# ± [002] 52 nonfatal myocardial infarction MI 52 adenoma recurrence 52 DAS# remission 52 restenosis reblockage 52 thrombotic complications 52 CRBSI 52 biochemical relapse 52 ventricular ejection fraction 52 CI -#.# 52 XIENCE V PROMUS Stent 52 intraoperative complications 52 neurodevelopmental impairment 52 silent ischemia 52 XIENCE V demonstrated 52 debulking surgery 52 nodal metastases 52 upper gastrointestinal bleeding 52 postoperative morbidity 52 CDI recurrence 52 repeat revascularization 52 troponin T 52 atheroma volume 52 ischemic complications 52 pCR 52 angiographic outcomes 52 atherosclerotic renal artery stenosis 52 posttransplant 52 rehospitalization 52 placebo p = 52 diameter stenosis 52 sternal wound infection 52 perioperatively 52 carotid endarterectomy CEA 52 #mmHg [001] 52 prospectively stratified 52 tachyarrhythmia 52 prespecified secondary 52 unfractionated heparin UFH 52 Crohn Disease Activity 52 NNT = 52 HDRS 51 rate variability HRV 51 lymphocyte count 51 venous thromboembolism 51 systolic dysfunction 51 cerebral oxygenation 51 PRADAXA #mg 51 HF hospitalization 51 revascularisation 51 BARACLUDE r 51 glycated hemoglobin HbA1c 51 recurrent UTI 51 Hb A1C 51 hepatic resection 51 Secondary efficacy endpoints 51 CCyR 51 ipsilateral stroke 51 p = .# [001] 51 beta blocker therapy 51 A1c levels 51 postop 51 nonfatal myocardial infarction 51 tenecteplase 51 colorectal adenoma 51 % CI #.#-#.# [004] 51 carotid IMT 51 Major Adverse Cardiac 51 recurrent ischemia 51 baseline HbA1c 51 mL/min/#.# m 2 51 echocardiographic parameters 51 Skin sterol 51 TAVR 51 anastomotic leak 51 Severity MSCS score 51 Y BOCS 51 patients undergoing CABG 51 statistically significant p = 51 IIIa inhibitors 51 cardiac dysfunction 51 graft occlusion 51 liver resection 51 revascularization procedure 51 cardiovascular hospitalizations 51 endophthalmitis 51 underwent coronary angiography 51 TAXUS p value 51 dose atorvastatin 51 asthma exacerbation 51 QTcF 51 p = .# [002] 51 PSA nadir 51 relapsed MM 51 sternal wound infections 51 idraparinux 51 % Confidence Interval 51 elective PCI 51 stent thromboses 51 prostate cancer CaP 51 revascularizations 51 undergoing coronary artery 51 preoperative PSA 51 adrenalectomy 51 eplerenone 51 bioavailable testosterone 51 thromboprophylaxis 51 urate lowering therapy 51 BSIs 51 CI #.#-#.# [002] 51 CLABSIs 50 neutrophil counts 50 Erythropoietic therapies may 50 SUVmax 50 thrombotic events 50 PCWP 50 P ≤ 50 NSTEMI 50 confidence interval #.#-#.# 50 Secondary endpoints included 50 heparin induced thrombocytopenia 50 embolic stroke 50 CLABSI 50 FluCAM arm 50 cilostazol 50 intracerebral haemorrhage 50 atherothrombotic events 50 hemodynamically stable 50 Preoperatively 50 arterial calcification 50 oncologic outcomes 50 Primary endpoints 50 symptomatic VTE 50 symptomatic carotid stenosis 50 carotid stenosis 50 postoperative complication 50 nonischemic 50 COPD exacerbations 50 hip BMD 50 microbiologically evaluable 50 CMV disease 50 pg ml 50 Hazard Ratio 50 radical prostatectomy RP 50 chronic GVHD 50 cerebrovascular events 50 ICD implantation 50 HbA1C 50 virologic failure 50 attain statistical significance 50 adefovir treated 50 pulmonary arterial 50 % CI #.#-#.# [006] 50 transfemoral 50 elevation myocardial infarction 50 HBeAg negative patients 50 severe exacerbations 50 ACR# response 50 ischemia driven 50 oral anticoagulation 50 NSTE ACS 50 Injury Severity Score 50 Hazard Ratio = 50 confidence intervals CIs 50 rFVIIa 50 Cypher Stent 50 #OHD 50 myocardial function 50 thrombosis 50 SLNB 50 Taxus Stent 50 sirolimus eluting stents 50 bypass graft CABG surgery 50 interquartile range 50 μg mL 50 nocturnal hypoglycaemia 50 cerebral vasospasm 50 nosocomial infection 50 noncardiac 50 mL kg 50 ejection fractions 50 Index CDAI 50 lymph node metastasis 50 angioplasty stenting 50 cirrhotic patients 50 pacemaker implantation 50 intracoronary 50 noninferiority 50 Cardiopulmonary bypass 50 venous blood clots 49 visceral metastases 49 extubation 49 acute coronary syndromes ACS 49 placebo p 49 TURBT 49 pretransplant 49 myocardial infarction stroke 49 HAQ DI 49 CI #.#-#.# [001] 49 elevated transaminases 49 seroprotection 49 de ath 49 perioperative morbidity 49 extracapsular extension 49 Secondary endpoints 49 recanalization 49 neointimal hyperplasia 49 tipranavir r 49 FOLFOX4 49 arteriography 49 clinically evaluable population 49 mL/min/#.# m2 49 thrombus formation 49 obstructive CAD 49 artery stenosis 49 noncardiovascular mortality 49 ventricular tachyarrhythmia 49 hemodynamically unstable 49 ARCOXIA 49 pulmonary dysfunction 49 aldosterone antagonists 49 DVT PE 49 β blockers 49 lumbar spine BMD 49 % CI #.#-#.# [002] 49 NMIBC 49 transradial PCI 49 secondary efficacy endpoint 49 postoperative radiotherapy 49 HYVET 49 coronary stenoses 49 nonoperative 49 HOMA IR 49 arterial thrombosis 49 CI #.#-#.# p = 49 ADCS CGIC 49 cardiopulmonary bypass CPB 49 advanced adenomas 49 R0 resection 49 Doxil ® 49 pegylated interferon alfa 2b 49 mmHg p = 49 Visual Analogue Scale VAS 49 antibiotic prophylaxis 49 nadroparin 49 NATRECOR R 49 hemoglobin A1c HbA1c 49 CDAI score 49 bloodstream infection 49 ulcer healing 49 Acute Coronary Syndromes ACS 49 arterial revascularization 49 mIU ml 49 venous thromboembolism VTE 49 baseline LDH 49 tamponade 49 ALT elevation 49 lopinavir r arm 49 VT VF 49 BENICAR HCT 49 univariate analysis 49 infective endocarditis 49 cardiovascular hospitalization 49 cytologic 49 ventricular dysfunction 49 preterm newborns 49 statistical significance p 49 viral titers 49 β = 49 Thrombolysis 49 antimicrobial prophylaxis 49 preoperative 49 coronary intervention 49 XL# administered orally 49 Coronary Artery Bypass Graft 49 ventricular tachyarrhythmias 49 CYPHER ® 49 5 Fluorouracil 49 target lesion revascularization 49 thrombocytopenic 49 #.#mg/dL 49 thromboembolic complications 49 Kaplan Meier analysis 49 antiplatelet medication 49 LVSD 49 kidney allograft 49 platelet activation 48 stent insertion 48 serum phosphorous 48 afterload 48 urinary albumin excretion 48 autologous SCT 48 LAGB 48 GG genotype 48 thromboses 48 efficacy evaluable 48 ischemic cardiomyopathy 48 chemoradiation therapy 48 carotid artery blockage 48 IPSS 48 hyperglycaemic 48 carotid artery stenting 48 paclitaxel eluting stents 48 epicardial 48 5-FU/LV 48 nonischemic cardiomyopathy 48 postoperative delirium 48 pelvic lymphadenectomy 48 plus dexamethasone 48 abdominal hysterectomy 48 non valvular atrial 48 Folfox 48 receiving ISENTRESS 48 renal allograft 48 ICD shocks 48 advanced adenoma 48 progression TTP 48 detrusor overactivity 48 mg BID dose 48 nonfasting triglyceride levels 48 p = #.# [002] 48 postoperative bleeding 48 uncoated stent 48 ADHF 48 hemodynamic instability 48 hyperhomocysteinemia 48 symptomatic intracerebral hemorrhage 48 vertebral fracture 48 pulmonary artery catheters 48 x ULN 48 underwent CABG 48 coronary bypass graft 48 electron beam computed tomography 48 distal embolization 48 DAS# [002] 48 TPV r 48 nonfatal MI 48 Zometa hazard 48 carotid endarterectomy 48 diagnostic angiography 48 chronic periodontitis 48 macrovascular events 48 ventricular remodeling 48 acid suppressive medication 48 macrovascular 48 CABG procedures 48 receiving VICTRELIS 48 serum clusterin levels 48 paroxysmal AF 48 MADRS score 48 CRT ICD 48 placebo fluoxetine 48 patency 48 LDL triglycerides 48 electrocardiographic 48 hepatorenal syndrome 48 intraoperative bleeding 48 dalteparin 48 ertapenem 48 oxycodone CR 48 PSADT 48 fatal myocardial infarction 48 liver transplant recipients 48 cranial irradiation 48 carotid plaque 48 VTEs 48 HBeAg 48 pericardial effusion 48 coronary revascularization procedures 48 drug eluting stent implantation 48 malperfusion 48 systemic embolism 48 atherothrombotic 48 colectomy 48 undergoing coronary angiography 48 pulmonary exacerbations 48 coagulopathy 48 underwent resection 48 antiplatelet agents 48 autonomic dysfunction 48 preserved ejection fraction 48 primary percutaneous coronary 48 posttreatment 48 hyperacute 48 haemodynamic 48 ICD implants 48 femoral neck fracture 48 RSV hospitalizations 48 interferon ribavirin 48 CDAI 48 -#.# log# 48 ischaemia 48 operable breast cancer 48 haematological toxicity 48 VTE 48 YMRS 48 mITT population 48 Sustained Virological Response 48 lung metastasis 48 atrioventricular block 48 achieved sustained virological 48 median sternotomy 48 subclinical hypothyroidism 48 mean baseline A1C 48 multivariate adjustment 48 CK MB 48 jugular venous 48 Free Survival PFS 48 serum concentrations 48 psychiatric comorbidity 48 REMICADE monotherapy 48 sinus node dysfunction 48 morbidity mortality 48 Cardiogenic shock 48 WOMAC pain 48 sUA 48 Coronary artery bypass 48 TAXUS Express Stent 48 multivariate Cox 48 -#.# log# copies mL 48 hemoglobin hematocrit 48 desvenlafaxine succinate 48 renal artery stenosis 48 psychiatric comorbidities 48 prolonged QT interval 48 anastomotic leaks 48 ALND 48 Score TOS 48 ATACAND 48 mm Hg 48 venous thrombosis 48 CI = 47 arteriovenous fistula 47 carotid surgery 47 Vascular Annual Meeting 47 Score DAS# 47 vasopressor 47 nitroprusside 47 sustained virologic response 47 acute STEMI 47 liver metastasis 47 nonmetastatic 47 doxorubicin docetaxel 47 microvascular complications 47 SELENA SLEDAI score 47 Non inferiority 47 sustained ventricular tachycardia 47 mediastinitis 47 MitraClip device 47 statistically significant p 47 revascularization procedures 47 serologically active patients 47 postoperative hemorrhage 47 intracerebral hemorrhage ICH 47 asymptomatic PAD 47 bacteremia 47 Fibromyalgia Impact Questionnaire 47 residual stenosis 47 noninferior 47 VLBW infants 47 COPD exacerbation 47 Decompensated Heart Failure 47 -#.# mg dL [001] 47 Fontan procedure 47 pancreatic resection 47 bronchopulmonary dysplasia 47 achieved CCyR 47 carotid artery stenosis 47 coronary vessels 47 aldosterone antagonist 47 atherothrombotic disease 47 decompensated heart failure 47 systolic function 47 cytoreductive surgery 47 ROC curve 47 arterial stiffening 47 underwent angiography 47 coinfected patients 47 graft dysfunction 47 abdominal aortic 47 clinically meaningful improvement 47 virological response 47 unstable angina UA 47 tHcy 47 severe neutropenia 47 bradycardia 47 β blocker 47 D dimer 47 IQR 47 mIU L 47 QRS duration 47 nephron sparing surgery 47 stem cell engraftment 47 artery bypass 47 mg kg dose 47 SLE Responder Index 47 pretest probability 47 CALGB # [002] 47 median survivals 47 locoregional control 47 gastrointestinal perforations 47 prednisone prednisolone plus 47 detectable HCV RNA 47 hypoperfusion 47 ezetimibe simvastatin 47 reblockage 47 cerebrovascular accidents 47 fluticasone salmeterol 47 achieved ACR# 47 mRCC 47 LV ejection fraction 47 seropositive patients 47 intravenous diuretics 47 postsurgical 47 nasal symptom 47 aneurysmal subarachnoid hemorrhage 47 eptifibatide 47 epoetin alpha 47 Cardiorespiratory fitness 47 coronary artery occlusion 47 Bloodstream Infections 47 endoscopic remission 47 lymphadenectomy 47 artery occlusion 47 ventricular tachycardias 47 Angiotensin converting enzyme 47 cystoid macular edema 47 cecal intubation 47 remission CR 47 CVD mortality 47 ECOG PS 47 IPAH 47 revascularization 47 hemodynamic parameters 47 ARB telmisartan 47 Endarterectomy 47 acute myocardial infarction AMI 47 conditional logistic regression 47 methotrexate monotherapy 47 sociodemographic factors 47 acute aortic dissection 47 node metastases 47 colorectal neoplasms 47 intraperitoneally 47 multivariable adjusted 47 severe hypoglycemic 47 VTE prophylaxis 47 coronary artery bypass graft 47 gm dl 47 Target Lesion Revascularization TLR 47 reintubation 47 glycated hemoglobin 47 oral diclofenac 47 CIMZIA ™ 47 sodium nitroprusside 47 FFNS 47 percutaneous intervention 47 renarrowing 47 Invasive Breast Cancer 47 stroke myocardial infarction 47 liposome injection 47 BMS p = 47 adjuvant radiotherapy 47 Engerix B 47 gastric varices 47 rho = 47 Kaplan Meier 47 salmeterol fluticasone propionate 47 CIMZIA TM 47 -#.# mg dL [002] 47 aspirin beta blockers 47 Kaplan Meier estimate 47 radical nephrectomy 47 stenting procedures 47 CAUTI 47 CIN2 + 47 cardiac biomarkers 47 postoperative chemotherapy 47 statistical significance p = 47 trabeculectomy 47 ABSORB trial 47 RBC transfusion 47 paroxysmal supraventricular tachycardia 47 MMSE scores 47 cytogenic 47 persistency mortality 47 biopsy Gleason 47 antiretroviral naïve 47 Montgomery Åsberg Depression 47 nonsevere 47 coronary 47 Coronary Artery Bypass Grafting 47 estimated glomerular filtration 47 spontaneous preterm delivery 46 daily Infergen 46 #mm Hg 46 ratio ICER 46 triglyceride concentrations 46 mcg BID 46 Acute Decompensated Heart Failure 46 FFR guided 46 preoperative chemotherapy 46 HAM D# scores 46 radiochemotherapy 46 mITT 46 Montgomery Asberg Depression 46 UPDRS motor 46 asymptomatic carotid stenosis 46 INVEGA ® 46 carotid plaques 46 MELD scores 46 underwent liver transplantation 46 angiographically 46 noncarriers 46 noncardiac surgery 46 dyssynchrony 46 repeat paracentesis 46 Platelet counts 46 HSCT 46 p = #.# [004] 46 multivariable logistic regression 46 Garcia Manero 46 logistic regression analysis 46 PaO 2 46 NIH CPSI 46 CT coronary angiography 46 response pCR 46 MMSE score 46 IFN alfa 46 amoxicillin clavulanate 46 diastolic function 46 virologic response 46 UA NSTEMI 46 ß blockers 46 CYP#D# genotype 46 adjunctive placebo 46 nodal metastasis 46 adenoidectomy 46 NSQIP 46 coronary artery bypass grafts 46 plus aztreonam 46 Readmissions 46 PLX STROKE targeting 46 MULTAQ 46 TWYNSTA 46 stented vessel 46 pulmonary exacerbation 46 antitumor effect 46 undergo percutaneous coronary 46 highest tertile 46 endarterectomy 46 C difficile infection 46 events MACE 46 adjuvant radiation 46 pump CABG 46 interrater reliability 46 invasive coronary angiography 46 mucosal inflammation 46 atrial arrhythmias 46 distant metastases 46 QIDS SR 46 CD# upregulation 46 peritoneal carcinomatosis 46 histological subtype 46 moderate renal impairment 46 iodixanol 46 valvular disease 46 Angiographic 46 bivalirudin alone 46 histologically proven 46 esophagectomy 46 wound dehiscence 46 epirubicin cyclophosphamide 46 EDSS score 46 Charlson Comorbidity Index 46 CRBSIs 46 allogeneic HSCT 46 MIs 46 portal vein thrombosis 46 achieving sustained virologic 46 spontaneous bacterial peritonitis 46 antiplatelet therapy 46 carotid intima media 46 hemodilution 46 oral anticoagulant therapy 46 p = 46 cytoreduction 46 coronary revascularization 46 myocardial ischemia 46 creatinine ratio 46 multivariate adjusted 46 + PH# 46 functional mitral regurgitation 46 odds ratios ORs 46 distant metastasis 46 ACR Pedi 46 NIHSS 46 invasive carcinomas 46 Stroke Scale NIHSS 46 artery reclogging 46 Afib 46 resected pancreatic cancer 46 DLQI 46 coronary ischemia 46 chemosensitivity 46 endobronchial 46 severe hypoglycemia 46 antithymocyte globulin 46 ACR# [002] 46 CMV reactivation 46 ispinesib administered 46 normotensive 46 urolithiasis 46 myocardial infarction 46 hepatectomy 46 revision arthroplasty 46 mL sec 46 hemodynamics 46 reoperations 46 KRAS mutant tumors 46 RECIST Response Evaluation Criteria 46 Scale EDSS 46 superficial femoral 46 multivariable analysis 46 cardiac tamponade 46 tension pneumothorax 46 Viral load 46 Median progression 46 vasospasm 46 atorvastatin #mg 46 cardiovascular mortality 46 nonobstructive 46 acute myocardial infarction 46 radiotherapy RT 46 APACHE II 46 hypoxemia 46 nonsignificant 46 antibody mediated 46 tipranavir ritonavir 46 BENICAR 46 recurrent GBM patients 46 paroxysmal atrial fibrillation 46 limb salvage 46 TT genotype 46 PICSO ® 46 acute coronary 46 left ventricular LV 46 CNS LS 46 Flu Cy 46 seropositivity 46 multivessel disease 46 intracerebral 46 CRp 46 tachyarrhythmias 46 MRSA bloodstream infection 45 Hypotension 45 Clostridium difficile infections 45 coronary blockages 45 venous thromboembolic 45 organ perfusion 45 LOCF 45 pegylated interferon alfa 45 bronchioloalveolar carcinoma 45 nonfatal stroke 45 prognostic variables 45 cardioembolic stroke 45 CHD mortality 45 cerebral ischemia 45 Stroke Scale 45 albumin excretion rate 45 ejection fraction EF 45 Brief Psychiatric 45 perinatal asphyxia 45 renal transplantation 45 IBDQ 45 multivariate analyzes 45 perinatal mortality 45 vertebrobasilar 45 chemoradiotherapy 45 biochemical recurrence 45 coronary vascular 45 SVR# 45 intracerebral hemorrhage 45 hemoglobin concentration 45 undetectable HBV DNA 45 Randomized clinical trials 45 tolterodine ER 45 completely resected 45 urine albumin 45 RBC transfusions 45 androgen deprivation 45 ritonavir boosted 45 distensibility 45 Complication rates 45 antenatal corticosteroids 45 Adjuvant chemotherapy 45 intra abdominal abscess 45 tortuosity 45 PREZISTA r arm 45 antioxidant supplementation 45 symptom exacerbation 45 ACTEMRA TM 45 lowest tertile 45 CABG surgeries 45 fibrinolytic therapy 45 hematologic toxicity 45 neoadjuvant radiation 45 TNSS 45 death reinfarction 45 cytogenetic response 45 treat NNT 45 nonoperative treatment 45 SELENA SLEDAI 45 BEXXAR Therapeutic Regimen 45 pT2 45 Thoracic Surgeons STS 45 PCI percutaneous coronary 45 μmol L 45 atheroma 45 log# reduction 45 abacavir lamivudine 45 comorbid illnesses 45 tumor progression TTP 45 hyperglycaemia 45 ‰ ¥ 45 T1a 45 thromboembolic disease 45 haematopoietic 45 seminal vesicle invasion 45 NIHSS score 45 intra arterial 45 imatinib therapy 45 plus prednisone 45 Xalatan R 45 lowering blood glucose 45 Postoperative complications 45 empyema 45 allogeneic SCT 45 coronary artery revascularization 45 neurodevelopmental outcome 45 cardioplegic arrest 45 Ebstein anomaly 45 rituximab refractory 45 atrophic gastritis 45 undergoing CABG 45 neoadjuvant treatment 45 cabazitaxel 45 contractile function 45 pretreatment serum 45 nonsignificant difference 45 Rating Scale BPRS 45 pancreatic adenocarcinoma 45 postoperative complications 45 Arch Intern Med 45 arterial occlusion 45 bivalirudin monotherapy 45 neurocognitive deficits 45 computed tomography angiography 45 postoperative 45 radial artery grafts 45 Response Evaluation Criteria 45 median PFS 45 malignant neoplasm 45 FOLFIRI alone 45 perfusion defects 45 TAXUS stent 45 low birthweights 45 mcg Albuferon 45 Bronchopulmonary Dysplasia 45 undetectable PSA 45 haemorrhagic stroke 45 pegylated IFN 45 hormone receptor negative 45 granulocyte 45 Rating Scale MADRS 45 β cell 45 pmol L 45 GWTG CAD 45 VcMP 45 bypass graft 45 EDSS scores 45 clinicopathological 45 spontaneous circulation ROSC 45 -#.# mmol L 45 CR CRu 45 bowel resection 45 Stage IIB